ARTICLE | Clinical News
LEP-ETU paclitaxel: Phase I final data
May 23, 2005 7:00 AM UTC
Final data from an open-label, dose-escalation, U.S. Phase I trial showed that LEP-ETU infusion over 90 minutes was well tolerated. A maximum tolerated dose of 325 mg/m 2 was determined. Also, 4 patie...